BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Sotalol

An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.

297+ PubMed studies analyzed · 64 RCTs · Evidence Score: 56

Research Domains

Sotalol has been studied across 11 research domains including ❤️ Cardiovascular, 😴 Sleep, 🧠 Focus & Attention, 🫘 Kidney, 🦠 Gut & Microbiome. The primary research focus is ❤️ Cardiovascular with 71% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sotalol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Timolol
6 shared targets
Acebutolol
4 shared targets
Clenbuterol
5 shared targets
Propranolol
10 shared targets
Labetalol
9 shared targets
Atenolol
4 shared targets
Aztreonam
4 shared targets
Levalbuterol
5 shared targets
Levalbuterol
5 shared targets
Dexamethasone
5 shared targets
Loading evidence profile...

This evidence profile for Sotalol is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.